| Catalog Number |
SMN 10445146 |
| Medical Device Problem Code |
Low Test Results (2458)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
12/05/2023
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
A discordant falsely depressed total bilirubin (tbil) patient sample result was obtained on a dimension vista 500 system.The falsely depressed result was not reported to the physician(s).The same sample was reprocessed on the same dimension vista 500 system and obtained higher result.The reprocessed result was considered correct and reported to the physician(s).There are no known reports of patient intervention or adverse health consequences due to the falsely depressed total bilirubin (tbil) patient result.
|
| |
|
Additional Manufacturer Narrative
|
|
A united states customer contacted the siemens customer care center (ccc) regarding a falsely depressed total bilirubin (tbil) patient result obtained on a dimension vista 500 system.Hsc evaluated the information provided by the customer and the available instrument data logs.Calibration and quality control recovered within the customer's expected ranges.Repeat of the same samples yielded the expected results.Hsc concluded that the cause of the event suggests the event was related to a specific well.There may have been less reagent volume present or reagent precipitation within that specific well.Siemens is investigating this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information on (25-jan-2024): siemens healthcare diagnostics headquarters support center (hsc) concluded the investigation of the event.Hsc reviewed the instrument data files and the information provided by the customer.Calibration was within the customer¿s acceptable ranges.Quality control (qc) was within range for both levels.Hsc concluded that the cause of the falsely depressed result was isolated to a specific well within a single flex.The well may have experienced insufficient volume or precipitation.The customer is operational.Siemens is investigating this event.Initial mdr 2517506-2024-00019 was filed with the fda on 16-jan-2024.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information (23-july-2024): siemens healthineers has confirmed the potential for discordant total bilirubin (tbil) results when the last three tests from the 160 test flex of lot 23206ba (wells 8 or 10) were processed on the dimension vista® platform.Us customers were notified through an urgent medical device correction (umdc, letter vc24-02.A.Us) and ous customers were identified through urgent field safety notice (ufsn, letter vc24-02.A.Ous) titled ¿dimension vista total bilirubin (tbil) lot 23206ba discordant results due to underfilled reagent wells¿.The communication was directed to all customers who received dimension® vista tbil flex reagent cartridge lot 23206ba informing them of the issue and providing instructions the customer must follow.In section h6, the type of investigation, investigation finding and investigation conclusion codes were updated.Initial mdr 2517506-2024-00019 was filed on 16-jan-2024.Mdr 2517506-2024-00019 supplemental report 1 was filed on 16-feb-2024.
|
| |
|
Search Alerts/Recalls
|